These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31776290)

  • 21. KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling.
    DiStefano PV; Kuebel JM; Sarelius IH; Glading AJ
    J Biol Chem; 2014 Nov; 289(47):33054-65. PubMed ID: 25320085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.
    Jenny Zhou H; Qin L; Zhang H; Tang W; Ji W; He Y; Liang X; Wang Z; Yuan Q; Vortmeyer A; Toomre D; Fuh G; Yan M; Kluger MS; Wu D; Min W
    Nat Med; 2016 Sep; 22(9):1033-1042. PubMed ID: 27548575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
    Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
    J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice.
    Chan AC; Drakos SG; Ruiz OE; Smith AC; Gibson CC; Ling J; Passi SF; Stratman AN; Sacharidou A; Revelo MP; Grossmann AH; Diakos NA; Davis GE; Metzstein MM; Whitehead KJ; Li DY
    J Clin Invest; 2011 May; 121(5):1871-81. PubMed ID: 21490399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
    Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Description of Two Families with New Mutations in Familial Cerebral Cavernous Malformations Genes.
    Iruzubieta P; Campo-Caballero D; Equiza J; Albajar I; Sulibarría N; Sáez R; Andrés N; Mondragón E; Zulaica M; de Arce A; Urtasun M; López de Munain A
    J Stroke Cerebrovasc Dis; 2021 Dec; 30(12):106130. PubMed ID: 34597987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
    McDonald DA; Shi C; Shenkar R; Gallione CJ; Akers AL; Li S; De Castro N; Berg MJ; Corcoran DL; Awad IA; Marchuk DA
    Hum Mol Genet; 2014 Aug; 23(16):4357-70. PubMed ID: 24698976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective autophagy is a key feature of cerebral cavernous malformations.
    Marchi S; Corricelli M; Trapani E; Bravi L; Pittaro A; Delle Monache S; Ferroni L; Patergnani S; Missiroli S; Goitre L; Trabalzini L; Rimessi A; Giorgi C; Zavan B; Cassoni P; Dejana E; Retta SF; Pinton P
    EMBO Mol Med; 2015 Nov; 7(11):1403-17. PubMed ID: 26417067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCM3 and cerebral cavernous malformation disease.
    Wang K; Zhou HJ; Wang M
    Stroke Vasc Neurol; 2019 Jul; 4(2):67-70. PubMed ID: 31338212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EndMT contributes to the onset and progression of cerebral cavernous malformations.
    Maddaluno L; Rudini N; Cuttano R; Bravi L; Giampietro C; Corada M; Ferrarini L; Orsenigo F; Papa E; Boulday G; Tournier-Lasserve E; Chapon F; Richichi C; Retta SF; Lampugnani MG; Dejana E
    Nature; 2013 Jun; 498(7455):492-6. PubMed ID: 23748444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers.
    Abou-Fadel J; Qu Y; Gonzalez EM; Smith M; Zhang J
    Oncol Rep; 2020 Jun; 43(6):1945-1963. PubMed ID: 32186778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving clinical interpretation of five KRIT1 and PDCD10 intronic variants.
    Fusco C; Nardella G; Petracca A; Ronchi D; Paciello N; Di Giacomo M; Gambardella S; Lanfranconi S; Zampatti S; D'Agruma L; Micale L; Castori M
    Clin Genet; 2021 Jun; 99(6):829-835. PubMed ID: 33604894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
    Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
    Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.
    Fisher OS; Boggon TJ
    Cell Mol Life Sci; 2014 May; 71(10):1881-92. PubMed ID: 24287896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deciphering impact of single nucleotide polymorphisms on cotranscriptional modification in CCM gene mRNAs.
    Scimone C; Donato L; Alibrandi S; Alafaci C; D'Ascola A; Vinci S; D'Angelo R; Sidoti A
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1274-C1284. PubMed ID: 36094437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.
    Phillips CM; Stamatovic SM; Keep RF; Andjelkovic AV
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.
    Retta SF; Perrelli A; Trabalzini L; Finetti F
    Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
    Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
    J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification of protease-activated receptors signaling in sporadic cerebral cavernous malformation endothelial cells.
    Scimone C; Alibrandi S; Donato L; De Gaetano GV; Fusco C; Nardella G; Castori M; Rinaldi C; Alafaci C; Germanò A; D'Angelo R; Sidoti A
    Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119474. PubMed ID: 37030452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.